|
2-hydroxy-38-(methylthio)butanamide
|
Tri-POC替諾福韋二聚體
|
1093279-77-6
|
|
Rosuvastatin EP Impurity A
|
|
1260939-66-9
|
|
|
阿比特龍雜質(zhì)4
|
|
|
Baricitinib Impurity I
|
|
60547-97-9
|
|
Varenicline Impurity D
|
|
109351-34-0
|
|
ABiraterone impurity 7
|
阿比特龍雜質(zhì)7
|
|
|
Ezetimibe (SSR)-Isomer
|
|
70843-11-7
|
|
Doxazosin EP Impurity H
|
|
102839-00-9
|
|
Ticagrelor Impurity H
|
替格瑞洛雜質(zhì)H
|
1251765-07-7
|
|
(S)-1-(3-(4-amino-3-(4-phenoxyphenyl)
|
(S)-依魯替尼
|
936563-97-2
|
|
Terazosin Impurity8
|
|
109678-71-9
|
|
Tofacitinib IMpurity 5
|
托法替尼雜質(zhì)5
|
1062580-52-2
|
|
ABiraterone impurity 2
|
阿比特龍雜質(zhì)2
|
|
|
(1R,2R)-2-(3,4-difluorophenyl)
|
替格瑞洛雜質(zhì)B
|
1459719-81-3
|
|
Vinpocetine impurity 20
|
長春西汀雜質(zhì)20
|
57327-92-1
|
|
Vinpocetine impurity D
|
長春西汀雜質(zhì)D
|
57517-54-1
|
|
1-(2-((2,3-dimethylphenyl)thio)phenyl)piperazine
|
沃替西汀雜質(zhì)4
|
1293489-77-6
|
|
Vinpocetine impurity G
|
長春西汀雜質(zhì)G
|
77549-94-1
|
|
Vinpocetine impurity O
|
長春西汀雜質(zhì)O
|
57430-34-9
|
|
Vinpocetine impurity M
|
長春西汀雜質(zhì)M
|
18374-18-0
|
|
1,3-dimethyl-33-nitrosourea
|
|
60548-08-5
|
|
7-ACA Sulfoxide Impurity 3
|
7-ACA內(nèi)酯雜質(zhì)3
|
|
|
Nateglinide EP Impurity D
|
乙酰基半胱氨酸雜質(zhì) 3
|
63-91-2
|
|
Vinpocetine impurity B
|
長春西汀雜質(zhì)B
|
4880-92-6
|
|
Ezetimibe (SSR)-Isomer
|
托法替尼雜質(zhì)3
|
477600-74-1
|
|
Abiraterone Impurity 11
|
阿比特龍雜質(zhì)11
|
385804-67-1
|
|
Acetylcysteine Impurity 4
|
乙?；腚装彼犭s質(zhì)4
|
|
|
Varenicline Impurity D
|
醋酸烏利司他雜質(zhì)4
|
126784-99-4
|
|
Tofacitinib Impurity 1
|
托法替尼雜質(zhì)1
|
479633-63-1
|
|
Tofacitinib Impurity FD+DX
|
托法替尼雜質(zhì)FD+DX
|
91059-01-8
|
|
Valsartan Methyl Ester
|
|
1616761-00-2
|
|
Tofacitinib Impurity 10
|
托法替尼雜質(zhì)10
|
1204176-45-3
|
|
Prazosin EP Impurity B
|
哌唑嗪EP雜質(zhì)B
|
31350-27-3
|
|
1-(2-(o-tolylthio)phenyl)piperazine
|
沃替西汀雜質(zhì)1
|
1293489-71-0
|
|
Vinpocetine impurity 17
|
長春西汀雜質(zhì)17
|
59413-21-7
|
|
4-bromo-N-methylpicolinamide
|
|
1209459-88-0
|
|
Acetylcysteine impurity 19
|
乙酰基半胱氨酸雜質(zhì)1
|
15058-19-2
|
|
(E)-4-dimethylamino Crotonate Hydrochloride
|
(E)-4二甲胺巴豆酸乙酯鹽酸鹽
|
1255078-56-8
|
|
Terazosin Impurity10
|
|
40172-95-0
|
|
Vinpocetine impurity I
|
長春西汀雜質(zhì)I
|
6835-99-0
|
|
Abiraterone Impurity 8
|
阿比特龍雜質(zhì)8
|
32138-69-5
|
|
Tofacitinib ImpurityQ
|
|
1675248-19-7
|
|
α-Decitabine Impurity 2
|
α-地西他濱雜質(zhì)2
|
22432-95-7
|
|
Vinpocetine impurity L
|
長春西汀雜質(zhì)L
|
58000-63-8
|
|
Abiraterone Impurity 10
|
阿比特龍雜質(zhì)10
|
165334-69-0
|
|
Hydrochlorothiazide EP Impurity D
|
氫氯噻嗪雜質(zhì) E
|
5233-42-1
|
|
Tofacitinib Impurity 4
|
托法替尼雜質(zhì)4
|
923036-30-0
|
|
3-((3S,8R,9S,10R,13S,14S)
|
阿比特龍雜質(zhì)1
|
|
|
Ticagrelor Impurity G
|
替格瑞洛雜質(zhì)G
|
1445580-43-7
|
|
Vardenafil EP Impurity B
|
伐地那非EP雜質(zhì)B
|
437717-43-6
|
|
Vinpocetine impurity 18
|
長春西汀雜質(zhì)18
|
109741-24-4
|
|
Ezetimibe (SSR)-Isomer
|
沃替西汀雜質(zhì)6
|
1293489-74-3
|
|
Vinpocetine impurity E
|
長春西汀雜質(zhì)E
|
85647-43-4
|
|
Vinpocetine impurity N
|
長春西汀雜質(zhì)N
|
38990-16-8
|
|
Abiraterone Impurity 9
|
阿比特龍雜質(zhì)12
|
165334-72-5
|
|
Topiroxostat Impurity 2
|
托匹司他雜質(zhì)2
|
1992028-94-0
|
|
Acetylcysteine Impurity 10
|
乙酰基半胱氨酸雜質(zhì)10
|
|
|
Tofacitinib Impurity 9
|
托法替尼雜質(zhì)9
|
694495-63-1
|
|
Terazosin Impurity11
|
|
412334-56-6
|
|
Lactate tetramer
|
|
19237-84-4
|
|
ABiraterone impurity 3
|
阿比特龍雜質(zhì)3
|
|
|
Tofacitinib Impurity 2
|
托法替尼雜質(zhì)2
|
477600-73-0
|
|
Tofacitinib Impurity 11
|
托法替尼雜質(zhì)11
|
1206875-41-3
|
|
1-(2-(m-tolylthio)phenyl)piperazine
|
沃替西汀雜質(zhì)2
|
1293489-69-6
|
|
Velpatasvir
|
|
377049-84-7
|
|
Vorapaxar Impurity G
|
沃拉帕沙雜質(zhì)G
|
618385-10-7
|
|
Vardenafil EP Impurity C
|
伐地那非EP雜質(zhì)C
|
1255919-03-9
|
|
Vitamin B6 Impurity 80
|
醋酸烏利司他雜質(zhì)2
|
159681-66-0
|
|
Abiraterone Impurity 6
|
|
154229-20-6
|
|
Vorapaxar Impurity B
|
沃拉帕沙雜質(zhì)B
|
380894-77-9
|
|
Tofacitinib Impurity 13
|
托法替尼雜質(zhì)13
|
1354469-76-3
|
|
Vinpocetine impurity K
|
長春西汀雜質(zhì)K
|
83508-83-2
|
|
Terazosin Impurity17
|
|
547730-06-3
|
|
Acetylcysteine Impurity 2
|
乙?；腚装彼犭s質(zhì) 2
|
|
|
Rosuvastatin isomer(Z)-4
|
瑞舒伐他汀對接異構(gòu)體（Z式）-4
|
|
|
Tofacitinib Impurity 7
|
托法替尼雜質(zhì)7全套
|
90213-66-4
|
|
Acetylcysteine Impurity 13
|
|
26117-28-2
|
|
Vinpocetine impurity 16
|
長春西汀雜質(zhì)16
|
27773-65-5
|
|
Linagliptin Impurity CD10125
|
|
19216-56-9
|
|
Vinpocetine impurity F
|
長春西汀雜質(zhì)F
|
42971-12-0
|
|
Terazosin Impurity18
|
|
63074-07-7
|
|
Cilnidipine Impurity 46
|
哌唑嗪EP雜質(zhì)A
|
23680-84-4
|
|
Ticagrelor Impurity R
|
替格瑞洛雜質(zhì)R
|
1788033-05-5
|
|
Topiroxostat Impurity 1
|
B托匹司他雜質(zhì)1
|
2044702-36-3
|
|
Vinpocetine impurity H
|
長春西汀雜質(zhì)H
|
38990-17-9
|
|
Vinpocetine impurity J
|
長春西汀雜質(zhì)J
|
83508-82-1
|
|
Cefotaxime USP Impurity I
|
7-ACA
|
957-68-6
|
|
Terazosin Impurity5
|
|
84050-22-6
|
|
Tofacitinib Impurity 6
|
托法替尼雜質(zhì)6
|
3680-69-1
|
|
Alogliptin
|
曲格列汀雜質(zhì)T
|
850649-61-5
|
|
Tofacitinib Impurity 8
|
托法替尼雜質(zhì)8
|
3430-27-1
|
|
Vinpocetine impurity A
|
長春西汀雜質(zhì)A
|
40163-56-2
|
|
Ticagrelor Impurity C
|
替格瑞洛雜質(zhì)C
|
376608-65-0
|
|
Ticagrelor Impurity D
|
替格瑞洛雜質(zhì)全套
|
274693-26-4
|
|
(1S,2R)-2-(3,4-difluorophenyl)
|
替格瑞洛雜質(zhì)A
|
1345413-20-8
|
|
1-(2-(p-tolylthio)phenyl)piperazine
|
沃替西汀雜質(zhì)3
|
508233-82-7
|
|
Ticagrelor Impurity F
|
替格瑞洛雜質(zhì)F
|
1616703-93-5
|
|
Tetrahydro-2-furoic acid
|
|
16874-33-2
|
|
Vardenafil N-Oxide Impurity
|
N-氧化伐地那非
|
448184-48-3
|
|
7-ACA lactone Impurity 2
|
7-ACA內(nèi)酯雜質(zhì)2
|
|